Bausch Health Files 8-K on Shareholder Vote Matters
Ticker: BHC · Form: 8-K · Filed: Oct 9, 2025 · CIK: 885590
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing-update
TL;DR
Bausch Health is holding a shareholder vote on Oct 7th.
AI Summary
Bausch Health Companies Inc. filed an 8-K on October 9, 2025, reporting on a submission of matters to a vote of security holders that occurred on October 7, 2025. The filing details the company's corporate structure and historical name changes, including its former names Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, and BIOVAIL CORP INTERNATIONAL.
Why It Matters
This filing indicates a formal process where Bausch Health Companies Inc. is presenting matters for a vote by its security holders, which could impact corporate governance or strategic decisions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- Valeant Pharmaceuticals International, Inc. (company) — Former Company Name
- BIOVAIL Corp (company) — Former Company Name
- BIOVAIL CORP INTERNATIONAL (company) — Former Company Name
- October 7, 2025 (date) — Date of earliest event reported
- October 9, 2025 (date) — Date of report
FAQ
What specific matters were submitted for a vote of security holders on October 7, 2025?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
When was the 8-K form filed with the SEC?
The 8-K form was filed on October 9, 2025.
What is Bausch Health Companies Inc.'s principal executive office address?
The principal executive offices are located at 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8.
What was Bausch Health Companies Inc. previously known as?
The company was formerly known as Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, and BIOVAIL CORP INTERNATIONAL.
What is the Standard Industrial Classification code for Bausch Health Companies Inc.?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 504 words · 2 min read · ~2 pages · Grade level 12.7 · Accepted 2025-10-09 07:02:47
Filing Documents
- bhc-20251007.htm (8-K) — 25KB
- 0000885590-25-000044.txt ( ) — 141KB
- bhc-20251007.xsd (EX-101.SCH) — 2KB
- bhc-20251007_lab.xml (EX-101.LAB) — 22KB
- bhc-20251007_pre.xml (EX-101.PRE) — 13KB
- bhc-20251007_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On October 7, 2025, Bausch Health Companies Inc. (the "Company") held a Special Meeting of Shareholders (the "Special Meeting"). At the Special Meeting, the shareholders of the Company voted on the approval of an ordinary resolution ratifying, confirming and approving the adoption of the Company's Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025, as amended and restated on August 25, 2025 (the "Rights Plan Agreement"), which is described in detail in the Company's Management Proxy Circular and Proxy Statement dated August 27, 2025. The results of the matter voted upon are as follows: Proposal No. 1: Approval of the Ratification, Confirmation and Approval of the Rights Plan Agreement The shareholders approved the ordinary resolution ratifying, confirming and approving the adoption of the Rights Plan Agreement. For Against 178,244,775 40,130,633
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 9, 2025 BAUSCH HEALTH COMPANIES INC. By: /s/ Seana Carson Seana Carson Executive Vice President, General Counsel